Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Modulus Alternatives is an established private credit platform based in Mumbai, India. Founded in 2018 and incorporated in January 2019, it focuses on providing private debt financing to mid-market companies across various sectors—including healthcare & pharmaceuticals—through closed-ended Category II Alternative Investment Funds (AIFs). The firm emphasizes capital protection and active portfolio management. Its first fund (Centrum Credit Opportunities Fund) achieved a gross IRR of 17% over five years with investments spanning multiple industries. As of early 2025, the firm manages its second fund and has deployed over INR 2,500 crore across more than 21 investments since inception.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Modulus Alternatives.